Pharmafile Logo

ISMPP EU

- PMLiVE

Sandoz partners with Samsung Bioepis to develop up to five biosimilars

The agreement will expand the pipeline and builds on an existing partnership

- PMLiVE

Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment

Quotient’s somatic genomics platform technology will be used to develop the treatment

Before and after

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Cuttsy + Cuttsy

- PMLiVE

Ipsen appoints Michelle Werner as Executive Vice President, President of North America

Werner previously held senior roles at Bristol Myers Squibb, AstraZeneca and Novartis

- PMLiVE

The digital age and the advance of AI – pushing communications to new heights

As new comms excellence opportunities abound, staying connected through core messaging remains critical

- PMLiVE

Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development

The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients

- PMLiVE

PM Society Board welcomes Frankie Everson and Mark Wheeler

Current Chair, Dom Marchant, will be stepping down, but will continue to oversee the Creativity for Good initiative

- PMLiVE

BMS’ Opdivo gets expanded FDA and EU approval for Hodgkin lymphoma

This type of cancer is the most common one diagnosed in teenagers

- PMLiVE

BOOST Pharma appoints Elaine Jones as Board Chair

Jones currently serves on multiple boards, including NextCure

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links